These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3329395)

  • 41. Expression of neuroendocrine markers in undifferentiated carcinomas of the gastrointestinal tract.
    Grabowski P; Scherübl H
    J Clin Oncol; 2005 Jul; 23(21):4795-6; author reply 4796-7. PubMed ID: 16034058
    [No Abstract]   [Full Text] [Related]  

  • 42. Isolation and structure of urogastrone and its relationship to epidermal growth factor.
    Gregory H
    Nature; 1975 Sep; 257(5524):325-7. PubMed ID: 1161035
    [No Abstract]   [Full Text] [Related]  

  • 43. Apoptosis and growth factors in parathyroid adenomas.
    Kvasnicka T; Wang W; Johansson H; Sandelin K; Grimelius L
    Horm Metab Res; 1997 Nov; 29(11):544-8. PubMed ID: 9479553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.
    Derynck R; Goeddel DV; Ullrich A; Gutterman JU; Williams RD; Bringman TS; Berger WH
    Cancer Res; 1987 Feb; 47(3):707-12. PubMed ID: 3467839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer.
    Srinivasan R; Benton E; McCormick F; Thomas H; Gullick WJ
    Clin Cancer Res; 1999 Oct; 5(10):2877-83. PubMed ID: 10537356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The expression and their significance of epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor during the intrahepatic cholangiocarcinoma carcinogenesis].
    Zhuang DY; Liang P; Fan XH; Chen H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):55. PubMed ID: 14761293
    [No Abstract]   [Full Text] [Related]  

  • 47. EGFR as a predictor of relapse in myxopapillary ependymoma.
    Verma A; Zhou H; Chin S; Bruggers C; Kestle J; Khatua S
    Pediatr Blood Cancer; 2012 Oct; 59(4):746-8. PubMed ID: 22190537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical and immunologic diagnosis of cancer. The timing of tests in tumor monitoring.
    Tate H
    Tumour Biol; 1987; 8(2-3):179-80. PubMed ID: 3329402
    [No Abstract]   [Full Text] [Related]  

  • 49. Growth factors: potential for the management of solid epithelial tumours.
    Jankowski JA
    Baillieres Clin Gastroenterol; 1996 Mar; 10(1):165-79. PubMed ID: 8732307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Why monitor angiogenic factors in patients' urine?
    Wellstein A
    J Natl Cancer Inst; 1994 Mar; 86(5):328-9. PubMed ID: 7508517
    [No Abstract]   [Full Text] [Related]  

  • 51. Strategies for identification of peptide growth factors.
    Siegfried JM
    Pharmacol Ther; 1992 Nov; 56(2):233-45. PubMed ID: 1297986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and immunologic diagnosis of cancer. General cancer tests.
    Laurence DJ
    Tumour Biol; 1987; 8(2-3):75-7. PubMed ID: 3329403
    [No Abstract]   [Full Text] [Related]  

  • 53. Proceedings of a Workshop on the Biochemical and Immunologic Diagnosis of Cancer.
    Tumour Biol; 1987; 8(2-3):58-180. PubMed ID: 3448765
    [No Abstract]   [Full Text] [Related]  

  • 54. Biochemical and immunologic diagnosis of cancer. Consensus report, 1987.
    Tumour Biol; 1987; 8(2-3):65-74. PubMed ID: 3448766
    [No Abstract]   [Full Text] [Related]  

  • 55. Growth factor receptors.
    Damjanov I
    Curr Top Pathol; 1991; 83():159-86. PubMed ID: 1848805
    [No Abstract]   [Full Text] [Related]  

  • 56. Epidermal growth factor receptors.
    Veale D; Gibson GJ
    Eur Respir J; 1989 Nov; 2(10):1022. PubMed ID: 2606191
    [No Abstract]   [Full Text] [Related]  

  • 57. The biological assay of epidermal growth factor in neonatal mice.
    Blosse PT; Fenton EL
    Biochim Biophys Acta; 1974 Jun; 354(1):57-60. PubMed ID: 4847064
    [No Abstract]   [Full Text] [Related]  

  • 58. Interactions between haemopoietic growth factors.
    Fuchs D; Artner-Dworzak E; Fuith LC; Reibnegger G; Wachter H
    Lancet; 1989 Jun; 1(8649):1266. PubMed ID: 2566807
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification of the yellow lupin growth inhibitor as (+)-abscisin II ((+)-dormin).
    Cornforth JW; Milborrow BV; Ryback G; Rothwell K; Wain RL
    Nature; 1966 Aug; 211(5050):742-3. PubMed ID: 5962112
    [No Abstract]   [Full Text] [Related]  

  • 60. Biochemical and immunologic diagnosis of cancer. Growth factors and growth factor receptors.
    Neville AM
    Tumour Biol; 1987; 8(2-3):130-3. PubMed ID: 3329395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.